Your browser doesn't support javascript.
loading
Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells.
Auer, Franziska; Ingenhag, Deborah; Pinkert, Stefan; Kracker, Sven; Hacein-Bey-Abina, Salima; Cavazzana, Marina; Gombert, Michael; Martin-Lorenzo, Alberto; Lin, Min-Hui; Vicente-Dueñas, Carolina; Sánchez-García, Isidro; Borkhardt, Arndt; Hauer, Julia.
Afiliación
  • Auer F; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Ingenhag D; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Pinkert S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Kracker S; Université Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Hacein-Bey-Abina S; INSERM UMR 1163, Human Lymphohematopoiesis Laboratory, Paris, France.
  • Cavazzana M; UTCBS CNRS UMR 8258, INSERM U1022, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Chimie Paris-Tech, Paris, France.
  • Gombert M; Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris-Sud, Hôpital Kremlin-Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France.
  • Martin-Lorenzo A; Université Paris Descartes, Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Lin MH; INSERM UMR 1163, Human Lymphohematopoiesis Laboratory, Paris, France.
  • Vicente-Dueñas C; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Sánchez-García I; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/ Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
  • Borkhardt A; Institute of Biomedical Research of Salamanca, Salamanca, Spain.
  • Hauer J; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Duesseldorf, Medical Faculty, Duesseldorf, Germany.
Oncotarget ; 8(44): 75797-75807, 2017 Sep 29.
Article en En | MEDLINE | ID: mdl-29100269
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania